Literature DB >> 19869122

THE TYPE OF PHAGOCYTIC CELL AND ITS RELATIVE PROPORTIONS IN HUMAN BONE MARROW AND SPLEEN, AS IDENTIFIED BY THE SUPRAVITAL TECHNIQUE, WITH SPECIAL REFERENCE TO PERNICIOUS ANEMIA.

C A Doan1.   

Abstract

In general, there is a reversal of the normal in the ratio of clasmatocytes in the spleen to clasmatocytes in the bone marrow in pernicious anemia, with a marked tendency toward the phagocytosis of young, immature, nucleated red blood cells in the bone marrow. The peripheral blood picture suggests that these cells had never been in circulation. The observations made do not indicate that the spleen takes any directly active part in an increased destruction of blood in pernicious anemia.

Entities:  

Year:  1926        PMID: 19869122      PMCID: PMC2131112          DOI: 10.1084/jem.43.3.289

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  2 in total

1.  Phagocytosis of Erythrocytes in the Bone Marrow, with Special Reference to Pernicious Anemia.

Authors:  F W Peabody; G O Broun
Journal:  Am J Pathol       Date:  1925-03       Impact factor: 4.307

2.  STUDIES ON THE MATURATION OF MYELOBLASTS INTO MYELOCYTES AND ON AMITOTIC CELL DIVISION IN THE PERIPHERAL BLOOD IN SUBACUTE MYELOBLASTIC LEUCEMIA.

Authors:  F R Sabin; C R Austrian; R S Cunningham; C A Doan
Journal:  J Exp Med       Date:  1924-11-30       Impact factor: 14.307

  2 in total
  3 in total

1.  THE RHYTHMIC RANGE OF THE WHITE BLOOD CELLS IN HUMAN, PATHOLOGICAL LEUCOPENIC AND LEUCOCYTIC STATES, WITH A STUDY OF THIRTY-TWO HUMAN BONE MARROWS.

Authors:  C A Doan; L G Zerfas
Journal:  J Exp Med       Date:  1927-08-31       Impact factor: 14.307

2.  A STUDY OF THE PERIVASCULAR TISSUES OF THE CENTRAL NERVOUS SYSTEM, WITH THE SUPRAVITAL TECHNIQUE.

Authors:  L S Kubie
Journal:  J Exp Med       Date:  1927-09-30       Impact factor: 14.307

3.  THE PRESENCE OF DESQUAMATED ENDOTHELIAL CELLS, THE SO CALLED CLASMATOCYTES, IN NORMAL MAMMALIAN BLOOD.

Authors:  F R Sabin; C A Doan
Journal:  J Exp Med       Date:  1926-05-31       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.